Cita APA

Cofiell, R., Kukreja, A., Bedard, K., Yan, Y., Mickle, A. P., Ogawa, M., . . . Faas, S. J. (2015). Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Blood.

Citación estilo Chicago

Cofiell, Roxanne, Anjli Kukreja, Krystin Bedard, Yan Yan, Angela P. Mickle, Masayo Ogawa, Camille L. Bedrosian, y Susan J. Faas. "Eculizumab Reduces Complement Activation, Inflammation, Endothelial Damage, Thrombosis, and Renal Injury Markers in AHUS." Blood 2015.

Cita MLA

Cofiell, Roxanne, et al. "Eculizumab Reduces Complement Activation, Inflammation, Endothelial Damage, Thrombosis, and Renal Injury Markers in AHUS." Blood 2015.